Aucta Pharmaceuticals Signs Commercial Manufacturing Agreement with Catalent for Vigabatrin Stick Pack Dosage Form

Aucta Pharmaceuticals Signs Commercial Manufacturing Agreement with Catalent for Vigabatrin Stick Pack Dosage Form Catalent Somerset, N.J. – September 4, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced a commercial supply agreement for Aucta Pharmaceuticals, Inc.’s (Aucta) vigabatrin. […]

Read More

Sherpa Clinical Packaging and De:terminence Announce Initiative to Help Rare Disease Patients Climb Mountains

Sherpa Clinical Packaging and De:terminence Announce Initiative to Help Rare Disease Patients Climb Mountains Sherpa Clinical Packaging Partnership will Raise Funds Dedicated to Purchasing Equipment and Training Programs for Rare Disease Patients   Sacramento and San Diego, CA, August 21, 2018 — Sherpa Clinical Packaging and De:terminence are pleased to announce a joint fundraiser to […]

Read More

Orthotopic PDX Models with Quantitative Pathology End Points Provide a New Standard in Translational Oncology Drug Development

Orthotopic PDX Models with Quantitative Pathology End Points Provide a New Standard in Translational Oncology Drug Development   Reveal Biosciences Orthotopic Patient-Derived Xenografts (PDX) Despite the rise of personalized approaches to the treatment of cancer, translating these therapies into a clinical setting still poses an exceptional challenge. This is highlighted in drug development where research […]

Read More

Catalent Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals, Inc.

Catalent Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals, Inc. SOMERSET, N.J., August 14, 2018 – Catalent, Inc. (NYSE: CTLT) (“Catalent”), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the successful completion of the previously announced tender offer by Catalent Boston, […]

Read More

CERTIS ONCOLOGY PARTNERS WITH REVEAL BIOSCIENCES TO OFFER ADVANCED PRE-CLINICAL ONCOLOGY SERVICES

CERTIS ONCOLOGY PARTNERS WITH REVEAL BIOSCIENCES TO OFFER ADVANCED PRE-CLINICAL ONCOLOGY SERVICES   SAN DIEGO, AUGUST 13, 2018. Certis Oncology Solutions and Reveal Biosciences today announced a strategic partnership in which the two companies will collaborate to provide an innovative, next-generation suite of pre-clinical oncology services.   Under the agreement, Reveal will leverage its Artificial […]

Read More

Nucleus Network- Business Development Consultant for California/West Coast

  Business Development Consultant for California/West Coast Business Development opportunity to represent and actively contribute to the continued growth of Australia’s largest and most successful Early Phase Clinical Research Group • Working with the World’s best Biotech/Pharma clients and CRO’s.   Nucleus Network Pty Limited (NN) is Australia’s largest Early Phase clinical trials business headquartered […]

Read More